MTI Biotech, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1990-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.mtibiotech.com
2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients
Phase 1
Not yet recruiting
- Conditions
- Alzheimer DiseaseMild Cognitive Impairment
- Interventions
- Other: Placebo
- First Posted Date
- 2024-05-29
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- MTI Biotech Inc
- Target Recruit Count
- 48
- Registration Number
- NCT06432166
- Locations
- 🇺🇸
Center for Cognitive Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States
© Copyright 2025. All Rights Reserved by MedPath